69 Pulmonary Embolism Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Pulmonary Embolism Studies in New York

NCT05990179Recruiting

Genomic Uniformed-Screening Against Rare Disease In All Newborns

The goal of this study is to learn how genomic sequencing technology can be used to effectively expand the conditions screened on newborn screening. Newborn screening ensures equity and allows all bab...

New York, NYNA100,000 participantsColumbia University

View Study Details

NCT03141021Recruiting

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor (MPNST) and precursor le...

New York, NY1,050 participantsWashington University School of Medicine

View Study Details

NCT04633655Recruiting

International CIPN Assessment and Validation Study

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an in...

New York, NY1,000 participantsUniversity of Milano Bicocca

View Study Details

NCT05301140Recruiting

Vivistim Registry for Paired VNS Therapy (GRASP)

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment...

New York, NY1,000 participantsMicroTransponder Inc.

View Study Details

NCT07209254Recruiting

Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension

A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient e...

New York, NYNA770 participantsJennifer Lewey, MD, MPH

View Study Details

NCT00588562Recruiting

Rare Kidney Stone Consortium Patient Registry

The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria (PH), Dent disease, Cystinuria and APRT deficiency. Th...

New York, NY730 participantsMayo Clinic

View Study Details

NCT07288398Recruiting

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with p...

New York, NYPHASE3540 participantsTenax Therapeutics, Inc.

View Study Details

NCT06319716Recruiting

LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomes

The overall goal of this study is to examine the efficacy of the video-based Diabetes Self-Management Education and Support (DSMES) (hereafter VIDEO), or the video-based DSMES+community health worker ...

New York, NYNA540 participantsNYU Langone Health

View Study Details

NCT06121011Recruiting

A Global Prospective Observational Registry of Patients With Pompe Disease

This is a global, multicenter, prospective, observational registry of patients with Pompe disease, including those with late-onset pompe disease (LOPD) and infantile-onset pompe disease (IOPD). Both u...

New York, NY500 participantsAmicus Therapeutics

View Study Details

NCT06725030Recruiting

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

The objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during free tissue transfer surgery and lymphovenous anastomosis surgery. The pri...

New York, NY455 participantsMMI (Medical Microinstruments, Inc.)

View Study Details

NCT06721819Recruiting

The SCOPE Trial: Sleep, Cognition, and Pain Bundle Vs. ERAS-cardiac for Postoperative Delirium

Sleep disturbances, cognitive reserve, and continuing pain and inflammation are other risk factors contributing to delirium (confusion and agitation) and neurocognitive decline (in the long term) foll...

New York, NYPHASE3406 participantsBeth Israel Deaconess Medical Center

View Study Details

NCT02332668Recruiting

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Researchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any of these: * Advanced, which means cance...

New York, NYPHASE1370 participantsMerck Sharp & Dohme LLC

View Study Details

NCT05884775Recruiting

Novel Digital Patient-Reported Outcomes Tool for Diabetes Management

Investigators will conduct a hybrid type 1 effectiveness-implementation randomized controlled trial (RCT) to evaluate the effectiveness of iMatter2 versus usual care on reduction in HbA1c at 12-months...

New York, NYNA353 participantsNYU Langone Health

View Study Details

NCT07318402Recruiting

Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study

This is a multicenter, single-arm, prospective, observational study designed to evaluate bronchoscopist radiation exposure during standard-of-care image-guided robotic-assisted bronchoscopy (RAB) for ...

New York, NY350 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07676565Recruiting

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will e...

New York, NY300 participantsIndiana University

View Study Details

NCT06730230Recruiting

Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients

This study seeks to evaluate the impact of a remote patient monitoring (RPM)-specific tech-enabled community health worker workforce on the use of RPM for the management of hypertension among Latinx p...

New York, NYNA300 participantsNYU Langone Health

View Study Details

NCT07535268Recruiting

REPRESENT-PF Registry

This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority pa...

New York, NY275 participantsVivek Reddy

View Study Details

NCT02780297Recruiting

Prospective Research Rare Kidney Stones (ProRKS)

The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria, Dent disease and aden...

New York, NY220 participantsMayo Clinic

View Study Details

NCT06991231Recruiting

The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty

The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that...

New York, NYNA215 participantsNYU Langone Health

View Study Details

NCT05361941Recruiting

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities

This is a pivotal, prospective, multi-center, randomized, concurrent control, patient and assessor-blinded study with two arms: a treatment arm (where subjects will be treated with the EP Granules wit...

New York, NYNA204 participantsElute, Inc.

View Study Details

NCT07293689Recruiting

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

The goal of this observational study is to learn about how the doctor decides how long to cut t the esophageal muscle during Per-Oral Endoscopic Myotomy (POEM) in patients with difficulty swallowing d...

New York, NY200 participantsNorthwestern University

View Study Details

NCT06614322Recruiting

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

The goal of this clinical trial is to determine whether quantitative sensory testing (QST) can be used to classify participants into pain sub-groups and predict who will respond best to certain pain t...

New York, NYPHASE2190 participantsUniversity of Rochester

View Study Details

NCT03813407Recruiting

An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia

Sodium zirconium cyclosilicate has been shown to be effective and safe in adults for the treatment of hyperkalaemia, and therefore it is expected to be beneficial in children. This study will evaluate...

New York, NYPHASE3140 participantsAstraZeneca

View Study Details

NCT06772831Recruiting

Cognitive Reappraisal Training for Borderline Personality (BPD)

Previous work by the group convinced the researchers to pursue development of focused cognitive reappraisal training as a novel approach to treatment of BPD, either as stand-alone treatment or in conc...

New York, NYNA130 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT05641753Recruiting

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

This is a prospective, interventional, cohort study, meaning that researchers will follow and observe a group of enrolled study participants over a period of time (one to two months) to gather informa...

New York, NYPHASE4125 participantsNYU Langone Health

View Study Details

NCT06672510Recruiting

Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)

This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subje...

New York, NYNA118 participantsAkura Medical

View Study Details

NCT05641831Recruiting

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

This phase II trial tests how well canakinumab works to prevent progression to cancer in patients with clonal cytopenias of unknown significance (CCUS). CCUS is a blood condition defined by a decrease...

New York, NYPHASE2110 participantsUma Borate

View Study Details

NCT04374305Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwannomatosis (NF2-SWN, formerly known as ne...

New York, NYPHASE2109 participantsScott R. Plotkin, MD, PhD

View Study Details

NCT06047405Recruiting

NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP

The goal of this study is to compare two different modes of noninvasive ventilation in hypercapnic respiratory failure. The investigators will compare AVAPS and BIPAP S/T and hypothesize that AVAPS wi...

New York, NYNA100 participantsNorthwell Health

View Study Details

NCT03202303Recruiting

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

This trial aims to study the efficacy and safety of cannabidivarin (CBDV) in children with ASD....

New York, NYPHASE2100 participantsMontefiore Medical Center

View Study Details

NCT06006637Recruiting

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects o...

New York, NYNA80 participantsState University of New York - Upstate Medical University

View Study Details

NCT06517225Recruiting

Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial

Children with speech sound disorder show diminished intelligibility in spoken communication and may thus be perceived as less capable than peers, with negative consequences for both socioemotional and...

New York, NYPHASE276 participantsNew York University

View Study Details

NCT05866562Recruiting

Dupilumab in the Treatment of Pediatric Alopecia Areata

This is a prospective, randomized, double-blind, placebo-controlled clinical trial. The study will take place at four sites. This trial will enroll a total of 76 children and adolescents with moderate...

New York, NYPHASE276 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT05551793Recruiting

Regeneron AA Multicenter (Dupilumab)

This is a prospective, randomized, double blind, placebo-controlled clinical trial. The study will take place at 4 sites. This trial will enroll a total of 68 patients with moderate to severe AA (affe...

New York, NYPHASE276 participantsEmma Guttman

View Study Details

NCT06647511Recruiting

Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

The goal of this observational study is to use digital health tracking to improve how high blood pressure and other health issues are detected in pregnant refugee women. The main questions this study ...

New York, NY75 participantsWeill Medical College of Cornell University

View Study Details

NCT07142252Recruiting

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (...

New York, NYPHASE266 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT07015996Recruiting

Efficacy of Tezepelumab in Peanut Oral Immunotherapy

The proposed study is a proof-of-concept Phase 2, double-blind, randomized placebo-controlled clinical trial evaluating the safety and efficacy of tezepelumab and peanut Oral Immunotherapy (OIT) for t...

New York, NYPHASE262 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT06915116Recruiting

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

The purpose of this study is to find out whether it is practical (feasible) to use acupuncture to treat period loss (amenorrhea) caused by chemotherapy treatment in people with cancer. The researchers...

New York, NYPHASE260 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07037771Recruiting

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

This multicenter, randomized, placebo-controlled study will evaluate the efficacy and safety of zodasiran subcutaneous (SC) injection in subjects 12 years of age and older with genetically or clinical...

New York, NYPHASE360 participantsArrowhead Pharmaceuticals

View Study Details

NCT05004987Recruiting

Aβ Dynamics in LLMD

This study will examine the biological factors that may modulate the relationship between depression and the development of Alzheimer's disease (AD). Since the direction of causation between depressio...

New York, NYPHASE460 participantsNYU Langone Health

View Study Details

NCT06836232Recruiting

An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis

This is a study to understand if taking VTX2735 is safe and effective in participants diagnosed with Recurrent Pericarditis (RP). Approximately 30 patients will take VTX2735. The study consists of a ...

New York, NYPHASE250 participantsZomagen Biosciences Ltd.

View Study Details

NCT04747236Recruiting

Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL

The purpose of this study is to find out whether the combination treatment of romidepsin and oral azacytidine is safe and effective in patients with Peripheral T-Cell Lymphoma (PTCL). This study will ...

New York, NYPHASE250 participantsUniversity of Virginia

View Study Details

NCT06401356Recruiting

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

The purpose of this study is to evaluate the long-term safety and the clinical benefit of pelabresib in patients with hematological and/or solid tumor indications or advanced malignancies. Additionall...

New York, NYPHASE350 participantsNovartis Pharmaceuticals

View Study Details

NCT07223944Recruiting

A Gaucher Disease Gene Therapy Trial With FLT201

This study is a Phase 3, non-randomized, multicenter, efficacy and safety study in adult patients with Gaucher disease Type 1, on stable treatment with enzyme replacement therapy (ERT) or substrate re...

New York, NYPHASE345 participantsSpur Therapeutics

View Study Details

NCT06811389Recruiting

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

The central hypothesis is that a peer coach-delivered intervention that includes cognitive behavioral principles combined with theory-driven patient education will improve health-related quality of li...

New York, NYNA42 participantsWeill Medical College of Cornell University

View Study Details

NCT07039019Recruiting

Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis

This research study aims to evaluate whether corticosteroids help prevent the recurrence of pleural effusions in patients with non-specific pleuritis diagnosed through pleural biopsy. It can lead to r...

New York, NYEARLY_PHASE140 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06283251Recruiting

PediRISE Feasibility

The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a stud...

New York, NYNA40 participantsDana-Farber Cancer Institute

View Study Details

NCT07073820Recruiting

A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

The purpose of this study is to learn about the long-term safety, tolerability and effects of the study medicine (PF-07868489) for the possible treatment of PAH. PAH is a condition in which there is h...

New York, NYPHASE236 participantsPfizer

View Study Details

NCT06577779Recruiting

An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening

The goal of this study is to extend the efficacy evidence of sustained release methylphenidate compound (JornayPM) in adults with Attention-deficit/hyperactivity disorder (ADHD). JornayPM has recently...

New York, NYPHASE430 participantsNYU Langone Health

View Study Details

NCT04555161Recruiting

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right hea...

New York, NYNA30 participantsAria CV, Inc

View Study Details

NCT06410313Recruiting

First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease

This is a prospective, open label, multicenter, single arm, first in human clinical study. Patients with infra-inguinal peripheral arterial disease appropriate for treatment with a femoro-popliteal s...

New York, NYNA30 participantsMedinol Ltd.

View Study Details

NCT07487948Recruiting

Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris

This study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adults with lichen planopilaris (LPP) or central centrifugal cicatricial alopecia (...

New York, NYPHASE230 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT04580420Recruiting

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis....

New York, NYPHASE228 participantsDicerna Pharmaceuticals, Inc., a Novo Nordisk company

View Study Details

NCT06712875Recruiting

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

Pediatric gliomas harboring BRAF-alterations, commonly BRAFV600 mutation or KIAA1549-BRAF fusion, are currently treated with either chemotherapy or mitogen activated protein kinase (MAPK) inhibitors, ...

New York, NYPHASE127 participantsAnn & Robert H Lurie Children's Hospital of Chicago

View Study Details

NCT06541847Recruiting

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with pr...

New York, NYPHASE225 participantsHealx Limited

View Study Details

NCT04872543Recruiting

A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)

The purpose of this study is to see whether the study drug ASTX727 is an effective treatment for people who have MPNST with a PCR2 mutation. ASTX727 is a combination of two drugs (cedazuridine and de...

New York, NYPHASE225 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07403604Recruiting

Effect of Insulin Lowering on Lipogenesis

The goal of this clinical trial is to compare a one-week course of diazoxide (2 mg/kg per dose x 14 doses) and placebo in people with obesity and insulin resistance (IR) with metabolic dysfunction-ass...

New York, NYPHASE125 participantsColumbia University

View Study Details

NCT07400198Recruiting

Gait and Bone Health in SMA

The objective of this study is to understand how spatiotemporal and kinetic gait parameters are associated with bone health in pwSMA who are receiving DMT. We hypothesize that gait parameters are asso...

New York, NY22 participantsJacqueline Montes

View Study Details

NCT07303907Recruiting

A Phase 2A Trial of DT402 for Autism Spectrum Disorder

A Phase 2A Trial of DT402 Open-Label Study in Adults with Autism Spectrum Disorder...

New York, NYPHASE220 participantsDefinium Therapeutics US, Inc.

View Study Details

NCT07508488Recruiting

Deucravacitinib in the Treatment of Cicatricial Alopecias

This is a prospective, open-label clinical trial, in which all participants will be treated with deucravacitinib for 48 weeks. Approximately 20 participants will be enrolled: 10 Central Centrifugal Ci...

New York, NYPHASE220 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT06413277Recruiting

Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for Treatment of Chronic Pelvic Pain: HOPE Trial

The aim of the study is to evaluate the effectiveness of using ECAP (electrically evoked compound action potential)-controlled CL (closed-loop) SCS (spinal cord stimulation) to treat chronic pelvic pa...

New York, NY20 participantsAinsworth Institute of Pain Management

View Study Details

NCT06668493Recruiting

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

The primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC. To help with this evaluation, a safety lead-in period will be conducte...

New York, NYPHASE120 participantsFerring Pharmaceuticals

View Study Details

NCT00567073Recruiting

Pompe Pregnancy Sub-Registry

This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the Pompe Registry, regard...

New York, NY20 participantsGenzyme, a Sanofi Company

View Study Details

NCT05642455Recruiting

SPEARHEAD-3 Pediatric Study

This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers....

New York, NYPHASE120 participantsAdaptimmune

View Study Details

NCT07290244Recruiting

Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

The goal of this clinical trial is to evaluate the safety and tolerability of a single dose of ER-100 in adults with optic nerve conditions, specifically Open Angle Glaucoma (OAG) and Non-Arteritic An...

New York, NYPHASE118 participantsLife Biosciences Inc.

View Study Details

NCT06919354Recruiting

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell the...

New York, NYPHASE116 participantsGentiBio, Inc

View Study Details

NCT06881992Recruiting

A Phase 3 Study of Ersodetug in Patients With Tumor-Associated Hyperinsulinism

The objectives of this study are to evaluate the glycemic efficacy, safety, and tolerability of ersodetug for treatment of hypoglycemia in patients with Tumor-Associated Hyperinsulinism (tHI)....

New York, NYPHASE316 participantsRezolute

View Study Details

NCT07539597Recruiting

Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations

This single-center, single-arm quasi-experimental study will assess the feasibility and acceptability of a community health worker (CHW)-led intervention to address social determinants of health (SDOH...

New York, NYNA15 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT07282847Recruiting

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)

This is a single-arm, open-label, dose-escalation study to evaluate the safety, tolerability and efficacy of a single intravenous infusion of AB-1009 in adult participants with late-onset Pompe diseas...

New York, NYPHASE112 participantsAskBio Inc

View Study Details

About Pulmonary Embolism Clinical Trials in New York

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 69 pulmonary embolism clinical trials recruiting participants in New York, NY. These studies are seeking a combined 112,413 participants. Research is being sponsored by Columbia University, Washington University School of Medicine, University of Milano Bicocca and 50 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in New York — FAQ

Are there pulmonary embolism clinical trials in New York?

Yes, there are 69 pulmonary embolism clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 69 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 16, 2026 from ClinicalTrials.gov